NUVB — Nuvation Bio Inc
In 2026 Q2, 6 of the 140 tracked hedge funds reported a position in Nuvation Bio Inc (NUVB), worth $46.19M combined. Over the quarter 5 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Duquesne | $25.79M | 0.59% | NO CHANGE |
| QVT | $8.27M | 0.53% | NEW |
| Renaissance | $7.65M | 0.01% | +140.7% |
| Essex | $3.81M | 0.50% | NEW |
| Quadrature | $659.52K | 0.00% | NEW |
| Persistent | $14.81K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.